Inhibitor drug 'primes' the body for anticancer immunotherapy
Labonline,
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe and may benefit some patients with advanced…
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe and may benefit some patients with advanced…
Immunotherapiesare emerging as a promising strategy for the treatment of late-stage cancers which currently have minimal…
Immunotherapiesare emerging as a promising strategy for the treatment of late-stage cancers which currently have minimal…
Immunotherapiesare emerging as a promising strategy for the treatment of late-stage cancers which currently have minimal…
【字体: 大 中 小 】 时间:2021年08月20日 来源:Johns Hopkins Medicine 编辑推荐: 根据一项1期临床试验的结果,将组蛋白去乙酰化酶抑制剂药物与免疫治疗药物相结合被认为是安全的,并可能使一些对传统治疗没有反应的晚期癌症患者受…
9 hours ago 1 Views Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some…
Combining a histone deacetylase inhibitor drug with immunotherapy agents has been deemed safe, and may benefit some patients…
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced…
Cancer cell during cell division. Credit: National Institutes of Health Combining a histone deacetylase inhibitor drug with…
Johns Hopkins Medicine From left: Evanthia Roussos Torres, Elizabeth Jaffee, Roisin Connolly and Vered Stearns.Credit: Courtesy…
Newswise — Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with…